Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Michigan Medical Genetics Laboratories, |
RCV000211009 | SCV000195882 | benign | Breast-ovarian cancer, familial, susceptibility to, 1 | 2014-11-03 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000506984 | SCV000602703 | benign | not specified | 2016-11-04 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000211009 | SCV001140635 | benign | Breast-ovarian cancer, familial, susceptibility to, 1 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001711989 | SCV001939539 | benign | not provided | 2019-08-19 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002485374 | SCV002798626 | benign | Familial cancer of breast; Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to, 4; Fanconi anemia, complementation group S | 2021-11-12 | criteria provided, single submitter | clinical testing | |
Clinical Genetics Laboratory, |
RCV000506984 | SCV001977616 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001711989 | SCV001977874 | likely benign | not provided | no assertion criteria provided | clinical testing |